Most cancers still have no routine screening test. Mammograms, colonoscopies, and Pap tests save lives for a few sites. Everything else is often found late — after symptoms. Multi-cancer early detection (MCED) is a physician-ordered blood draw that looks for circulating tumor DNA signals associated with 70+ cancer types in a single visit.
This is a screening tool, not a diagnosis. A signal means we investigate further with imaging and specialists. A negative result does not replace your mammogram, colonoscopy, or other guideline screening. Regenred orders the test, explains the limits in plain language, and owns the follow-up so you are not left alone with a report.
Every result is reviewed one-on-one with a medical provider. The goal is earlier detection where standard screening cannot look — without pretending a blood test can see everything.
What Multi-Cancer Early Detection Is — and Is Not
Think of MCED as a wide net for cancers that hide until they are advanced. It sits beside — never instead of — the screening you already do. That distinction is the whole point of a physician-led program.
One Blood Draw, 70+ Cancer Signals
A standard venous draw is sent for analysis of cell-free DNA patterns associated with dozens of cancer types. You do not need a separate imaging day to start. You do need a physician to interpret what a signal — or the absence of one — actually means.
Alongside Guideline Screening, Never Instead
Keep your mammogram, colonoscopy, and other recommended tests. MCED is built for cancers those tools do not cover well. Treating it as a replacement is how people miss treatable disease. We will not let that be the plan.
How the Test Works
The draw itself is straightforward. What matters is the science behind it, which cancers it can flag, and the protocol we follow if a signal appears. We walk through all three before you book.
Cell-Free DNA in the Blood
Tumors can shed fragments of DNA into circulation. The assay looks for methylation and related patterns that suggest a cancer signal and, when possible, a likely tissue of origin to guide the next scan — not to name a stage on the spot.
Broad Coverage, Honest Limits
The panel is designed to look across 70+ cancer types, including many with no routine screen. Sensitivity varies by type and stage. We explain those limits before you draw so expectations match the science, not the marketing.
A Signal Means a Workup, Not a Verdict
A positive signal is a reason to image and refer — not a cancer diagnosis. False positives happen. False negatives happen. The value is a structured next step owned by your Regenred physician, not a scary email.
From Result to a Clear Next Step
Results are not dumped into a portal. A Regenred physician explains what the report means, what it does not mean, and the next imaging or specialist step if one is needed.
Physician Review, Same Program
You sit down with a provider who has already read the report. We explain whether a signal was found, what the predicted origin implies, and whether watchful waiting or prompt imaging is the right move. Questions are expected.
Follow-Up We Coordinate
If further testing is indicated, we help sequence imaging and specialist referral so you are not navigating oncology scheduling alone. If the result is negative, we document that and keep your other screening on calendar.
Who This Test Is For
This test is typically considered for adults who want a broader screen than guidelines currently offer — especially those with family history, prior cancer, or a desire to add a blood-based layer to an already serious diagnostic plan. Eligibility is confirmed with a provider before the draw.
Adults Who Want a Wider Screen
Typically considered for adults who already take screening seriously and want an additional blood-based look at cancers with no routine test. It is not a shortcut around colonoscopy or mammography, and it is not for unexplained acute symptoms — those need diagnostic evaluation now.
Family History and Higher Concern
A strong family history, prior cancer, or simply a desire to be more thorough than guidelines require is a common reason to discuss MCED. Your physician will still confirm it is appropriate before we order it — some situations need genetics or imaging first.
How to Book
Multi-cancer early detection is how Regenred extends “measure first” to cancers that standard checkups miss. It is not a substitute for colonoscopy, mammography, or diagnostic workups when symptoms exist.
If a signal is found, we coordinate the next tests. If it is not, we still keep you on guideline screening and the rest of your diagnostic map — Total Wellness Panel, executive physical, genetic risk — so one blood test never becomes your only plan.
Ready to discuss whether MCED fits you? Request a consult and ask for Multi-Cancer Early Detection under Diagnostics & Testing. Your physician will confirm eligibility, explain false positives and false negatives, and only then schedule the draw.